Source: MarketScreener

Foros: Diplomat Pharmacy : Announces Review of Strategic Alternatives

(marketscreener.com) FLINT, Mich., Aug. 9, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) today announced that its Board of Directors is reviewing strategic alternatives. At the direction of its Board of Directors, the company is reviewing strategic alternatives focused on maximizing shareholder value. The...http://www.marketscreener.com/DIPLOMAT-PHARMACY-INC-18164874/news/Diplomat-Pharmacy-Announces-Review-of-Strategic-Alternatives-29040450/?utm_medium=RSS&utm_content=20190809

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Jean Manas's photo - Founder & CEO of Foros

Founder & CEO

Jean Manas

CEO Approval Rating

75/100

Read more